Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genomics02:02

Genomics

40.9K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.9K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

37.3K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.3K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

9.2K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.2K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

3.5K
3.5K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

17.1K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
17.1K
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

48.8K
The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
48.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Authors' Reply-2.

Indian journal of pediatrics·2026
Same author

Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial - Authors' Reply.

Indian journal of pediatrics·2026
Same author

Statin use is associated with reduced stroke risk after cranial radiation in glioma patients with hyperlipidemia.

Journal of neuro-oncology·2026
Same author

Inhaled Corticosteroids Plus Tiotropium Compared to Inhaled Corticosteroids Plus Montelukast in Children with Partly Controlled/Uncontrolled Asthma: A Non-Inferiority Trial.

Indian journal of pediatrics·2026
Same author

Not Just Half a Doctor: Promoting Humanism During Stressful Times.

Annals of the Child Neurology Society·2026
Same author

Symptomatic radiation necrosis after concurrent targeted therapy and stereotactic radiosurgery for brain metastases: a bicentric retrospective analysis.

Journal of neuro-oncology·2026

Related Experiment Video

Updated: Feb 14, 2026

Reusable Single Cell for Iterative Epigenomic Analyses
10:28

Reusable Single Cell for Iterative Epigenomic Analyses

Published on: February 11, 2022

1.7K

Brain cancer genomics and epigenomics.

Tenley C Archer1, Soma Sengupta2, Scott L Pomeroy1

  • 1Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States; Broad Institute of Harvard and MIT, Cambridge, MA, United States.

Handbook of Clinical Neurology
|February 27, 2018
PubMed
Summary

Molecular criteria are revolutionizing brain cancer diagnosis and treatment, improving precision in identifying cancer drivers and predicting patient outcomes. Understanding common molecular mechanisms is key to developing targeted therapies.

Keywords:
ETMRSWI/SNFcancer genomicsembryonal tumorsepigenomicsgliomamedulloblastomaprimitive neuroectodermal tumorsrhabdoid tumorsvon Hippel–Lindau disease

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.2K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.5K

Related Experiment Videos

Last Updated: Feb 14, 2026

Reusable Single Cell for Iterative Epigenomic Analyses
10:28

Reusable Single Cell for Iterative Epigenomic Analyses

Published on: February 11, 2022

1.7K
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

6.2K
CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
07:49

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery

Published on: May 30, 2025

2.5K

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Genetics

Background:

  • Traditional brain cancer diagnosis relies on histology and clinical criteria.
  • Recent advances in genomics and epigenomics enable molecular classification of tumors.
  • The 2016 WHO Classification of CNS Tumors incorporated molecular features.

Purpose of the Study:

  • To highlight the shift towards molecular criteria in brain cancer classification.
  • To identify common molecular mechanisms driving brain tumor development.
  • To emphasize the importance of understanding these mechanisms for targeted therapy.

Main Methods:

  • Review of recent advances in cancer genomics and epigenomics.
  • Analysis of molecular features in brain tumor classification.
  • Survey of common molecular events across the brain cancer landscape.

Main Results:

  • Molecular criteria enhance precision in identifying oncogenic drivers and predicting clinical outcomes.
  • Common themes driving brain cancers include DNA damage repair, genomic instability, and epigenetic dysfunction.
  • Pathways like mTOR and Sonic Hedgehog are implicated.

Conclusions:

  • Molecular classification represents a paradigm shift in neuro-oncology.
  • Understanding common molecular drivers is crucial for developing effective targeted therapies.
  • Precision medicine approaches require identifying the right patients for specific treatments.